Dr. Dan Eidman, M.D

NPI: 1649270059
Total Payments
$7,267
2024 Payments
$109.59
Companies
21
Transactions
84
Medicare Patients
295
Medicare Billing
$67,072

Payment Breakdown by Category

Consulting$4,530 (62.3%)
Food & Beverage$2,737 (37.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $4,530 2 62.3%
Food and Beverage $2,737 82 37.7%

Top Paying Companies

Company Total Records Latest Year
Kyocera Medical Technologies, Inc. $4,995 3 $0 (2021)
Heraeus Medical, LLC. $456.40 7 $0 (2022)
Horizon Therapeutics plc $277.18 20 $0 (2022)
Akrimax Pharmaceuticals, LLC $274.90 6 $0 (2017)
Amnio Technology, LLC $274.58 4 $0 (2018)
Vertical Pharmaceuticals, LLC $179.60 22 $0 (2018)
PFIZER INC. $122.48 1 $0 (2023)
Renovis Surgical Technologies, Inc. $121.62 1 $0 (2019)
Forte Bio-Pharma LLC $104.14 1 $0 (2018)
Life Spine, Inc. $94.05 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $109.59 5 SK Life Science, Inc. ($30.13)
2023 $162.08 3 PFIZER INC. ($122.48)
2022 $97.51 4 Heraeus Medical, LLC. ($60.03)
2021 $1,724 6 Kyocera Medical Technologies, Inc. ($1,480)
2020 $3,340 15 Kyocera Medical Technologies, Inc. ($3,050)
2019 $907.22 11 Kyocera Medical Technologies, Inc. ($465.22)
2018 $430.48 9 Amnio Technology, LLC ($274.58)
2017 $495.59 31 Akrimax Pharmaceuticals, LLC ($274.90)

All Payment Transactions

84 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
11/12/2024 SK Life Science, Inc. Food and Beverage In-kind items and services $30.13 General
09/18/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $25.09 General
Category: PARKINSONS DISEASE PSYCHOSIS
06/26/2024 Ossur Americas, Inc. Miami J (Device) Food and Beverage Cash or cash equivalent $7.87 General
Category: Bracing & Supports
05/14/2024 Otsuka America Pharmaceutical, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $23.52 General
Category: NEUROLOGY
02/05/2024 HARMONY BIOSCIENCES LLC WAKIX (Drug) Food and Beverage In-kind items and services $22.98 General
Category: Narcoplepsy
09/14/2023 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $122.48 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
05/10/2023 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $21.48 General
Category: Neurology
04/05/2023 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $18.12 General
Category: Neurology
08/15/2022 Kowa Pharmaceuticals America, Inc. Seglentis (Drug) Food and Beverage Cash or cash equivalent $19.66 General
Category: Pain Management
03/11/2022 Horizon Therapeutics plc PENNSAID (Drug) Food and Beverage In-kind items and services $17.82 General
Category: PENNSAID
02/28/2022 Heraeus Medical, LLC. PALACOS (Device) Food and Beverage In-kind items and services $20.92 General
Category: BONE CEMENT
01/31/2022 Heraeus Medical, LLC. PALACOS (Device) Food and Beverage In-kind items and services $39.11 General
Category: BONE CEMENT
10/14/2021 Life Spine, Inc. Nautilus (Device), ProLift, Gruve Food and Beverage Cash or cash equivalent $94.05 General
Category: Spinal Surgery
04/12/2021 Horizon Therapeutics plc PENNSAID (Drug) Food and Beverage In-kind items and services $12.07 General
Category: PENNSAID
03/03/2021 Next Science LLC Xperience (Device), SurgX Food and Beverage Cash or cash equivalent $73.33 General
Category: Surgical Site Infection
03/03/2021 HERAEUS MEDICAL, LLC. PALACOS (Device) Food and Beverage In-kind items and services $37.89 General
Category: BONE CEMENT
03/01/2021 Kyocera Medical Technologies, Inc. Consulting Fee Cash or cash equivalent $1,480.00 General
02/03/2021 HERAEUS MEDICAL, LLC. PALACOS (Device) Food and Beverage In-kind items and services $26.72 General
Category: BONE CEMENT
12/16/2020 Horizon Therapeutics plc DUEXIS (Drug) Food and Beverage In-kind items and services $11.38 General
Category: DUEXIS
12/04/2020 Horizon Therapeutics plc DUEXIS (Drug) Food and Beverage In-kind items and services $11.00 General
Category: DUEXIS
11/18/2020 Horizon Therapeutics plc DUEXIS (Drug) Food and Beverage In-kind items and services $9.81 General
Category: DUEXIS
11/04/2020 Horizon Therapeutics plc DUEXIS (Drug) Food and Beverage In-kind items and services $10.04 General
Category: DUEXIS
10/13/2020 Horizon Therapeutics plc DUEXIS (Drug) Food and Beverage In-kind items and services $16.21 General
Category: DUEXIS
09/14/2020 Horizon Therapeutics plc DUEXIS (Drug) Food and Beverage In-kind items and services $26.60 General
Category: DUEXIS
08/25/2020 Horizon Therapeutics plc DUEXIS (Drug) Food and Beverage In-kind items and services $10.38 General
Category: DUEXIS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 39 212 $212,100 $16,432
2022 1 41 102 $20,400 $6,725
2021 1 85 322 $61,325 $21,711
2020 2 130 423 $74,575 $22,204
Total Patients
295
Total Services
1,059
Medicare Billing
$67,072
Procedure Codes
5

All Medicare Procedures & Services

5 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 39 212 $212,100 $16,432 7.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 41 102 $20,400 $6,725 33.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 85 322 $61,325 $21,711 35.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 119 412 $72,100 $21,446 29.7%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 11 11 $2,475 $758.08 30.6%

About Dr. Dan Eidman, M.D

Dr. Dan Eidman, M.D is a Specialist healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649270059.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dan Eidman, M.D has received a total of $7,267 in payments from pharmaceutical and medical device companies, with $109.59 received in 2024. These payments were reported across 84 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($4,530).

As a Medicare-enrolled provider, Eidman has provided services to 295 Medicare beneficiaries, totaling 1,059 services with total Medicare billing of $67,072. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Sports Medicine
  • Location Houston, TX
  • Active Since 07/28/2005
  • Last Updated 07/22/2023
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1649270059

Products in Payments

  • PALACOS (Device) $456.40
  • DUEXIS (Drug) $285.89
  • Primlev (Drug) $274.90
  • LORZONE (Drug) $179.60
  • ELIQUIS (Drug) $122.48
  • Nalocet (Drug) $104.14
  • Nautilus (Device) $94.05
  • Xperience (Device) $73.33
  • PENNSAID (Drug) $70.66
  • Briviact (Drug) $39.60
  • NUPLAZID (Drug) $25.09
  • NUEDEXTA (Drug) $23.52
  • WAKIX (Drug) $22.98
  • Seglentis (Drug) $19.66
  • ZIPSOR (Drug) $17.89
  • RAMPART DUO INTERBODY FUSION SYSTEM (Device) $13.59
  • RAYOS (Drug) $13.48
  • Miami J (Device) $7.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Houston